Opinion | The Differences Between the Vaccines Matter
The Differences Between the Vaccines Matter – Vox
The post Opinion | The Differences Between the Vaccines Matter appeared first on Links Medicus.
Study Commentary | Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster
Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster – The Lancet Original study and news release: 3-month interval between first and second dose of Oxford COVID-19 vaccine results in higher vaccine efficacy than 6-week interval
The post Study Commentary | Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster appeared first on Links Medicus.
The role of C-reactive protein as a prognostic marker in COVID-19
The role of C-reactive protein as a prognostic marker in COVID-19 – International Journal of Epidemiology
The post The role of C-reactive protein as a prognostic marker in COVID-19 appeared first on Links Medicus.
Pregnancy and COVID: what the data say
Pregnancy and COVID: what the data say – Nature
The post Pregnancy and COVID: what the data say appeared first on Links Medicus.
Study: Home testing for COVID-19 could prevent infections and reduce deaths at justifiable cost
News release: Home testing for COVID-19 could prevent infections and reduce deaths at justifiable cost – Yale University Original study: Clinical and Economic Effects of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission – Annals of Internal Medicine Commentary on Twitter Model-based analysis by @ADPaltiel, Amy Zheng of @YaleMed and @PaulSaxMD of @BrighamWomens. A nationwide […]
The post Study: Home testing for COVID-19 could prevent infections and reduce deaths at justifiable cost appeared first on Links Medicus.
M-A: Serological evidence of human infection with SARS-CoV-2
Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis – The Lancet Global Health Invited Commentary: COVID-19 serosurveys for public health decision making – The Lancet Global Health Commentary on Twitter (thread – click for more) Now out: our systematic review and meta-analysis on seroprevalence surveys for SARS-CoV-2 is now out […]
The post M-A: Serological evidence of human infection with SARS-CoV-2 appeared first on Links Medicus.
Lab study shows Pfizer/BioNTech COVID-19 vaccine can also neutralize B.1.351, P1 and B.1.1.7 variants
Neutralizing Activity of BNT162b2-Elicited Serum – New England Journal of Medicine Commentaries: Expert reaction to NEJM correspondence paper looking at the neutralising activity of the Pfizer-BioNTech vaccine against SARS-CoV-2 variants in the lab – Science Media Centre AND Pfizer/BioNTech COVID-19 vaccine neutralizes Brazil variant in lab study – Reuters
The post Lab study shows Pfizer/BioNTech COVID-19 vaccine can also neutralize B.1.351, P1 and B.1.1.7 variants appeared first on Links Medicus.
USPSTF Statement: begin screening for lung cancer at age 50 years instead of 55 years for patients at risk
Recommendation Statement: Screening for Lung Cancer – US Preventive Services Task Force Editorials: Broadened Eligibility for Lung Cancer Screening: Challenges and Uncertainty for Implementation and Equity – JAMA AND Expanded Access to Lung Cancer Screening—Implementing Wisely to Optimize Health – JAMA Network Open AND New USPSTF Guidelines for Lung Cancer Screening: Better but Not Enough […]
The post USPSTF Statement: begin screening for lung cancer at age 50 years instead of 55 years for patients at risk appeared first on Links Medicus.
Restricting daily chest radiography in the ICU: Implementing evidence-based medicine to decrease utilization
Restricting Daily Chest Radiography in the Intensive Care Unit: Implementing Evidence-Based Medicine to Decrease Utilization – Journal of the American College of Radiology Commentary: Curbing daily use of chest x-ray in ICU cuts major costs – AuntMinnie (free registration required) Commentary on Twitter "Changing ordering practices in the adult ICUs to align with established […]
The post Restricting daily chest radiography in the ICU: Implementing evidence-based medicine to decrease utilization appeared first on Links Medicus.
RCT: 5 days of high-dose amoxicillin therapy noninferior to 10 days for the treatment of pediatric community-acquired pneumonia
Short-Course Antimicrobial Therapy for Pediatric Community-Acquired Pneumonia: The SAFER Randomized Clinical Trial – JAMA Pediatrics (free for a limited period) Editorial: Rightsizing Treatment for Pneumonia in Children Commentary: Five days of antibiotics fine for children with pneumonia – McMaster University Commentary on Twitter (thread – click for more) This is fantastic! In outpatient community […]
The post RCT: 5 days of high-dose amoxicillin therapy noninferior to 10 days for the treatment of pediatric community-acquired pneumonia appeared first on Links Medicus.